Trial Profile
Pharmacokinetics of imatinib, sildenafil and bosentan when administered alone or in combination in patients with severe pulmonary arterial hypertension
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Nov 2013
Price :
$35
*
At a glance
- Drugs Imatinib (Primary) ; Bosentan; Sildenafil
- Indications Pulmonary arterial hypertension
- Focus Pharmacokinetics
- 01 Nov 2013 New trial record
- 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.